Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision ...

Please provide your email address to receive an email when new articles are posted on . The American Society of Nephrology has announced the second year of its loan mitigation program, which provides ...

Please provide your email address to receive an email when new articles are posted on . The American Society of Nephrology launched its loan mitigation pilot program, committing $2,700,000 to selected ...